Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for OHSS Prevention in High-Risk Patients
NCT02686151Phase 3Unknown
- Sponsor
- Affiliated Hospital of Inner Mongolia Medical University
- Start
- Dec 2023
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of letrozole in ovarian hyperstimulation syndrome (OHSS), sponsored by Affiliated Hospital of Inner Mongolia Medical University. Status: unknown.
02
Drugs
letrozole
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT02686151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02686151.